Personal tools

UBERON:0002346

From FANTOM5_SSTAR

Jump to: navigation, search

Name:neurectoderm
Namespace:FANTOM
Definition:"Embryonic ectoderm that gives rise to nervous tissue." [Wikipedia:Neuroectoderm]
Xrefs:
links:

AAO:0011074
BILA:0000039
EHDAA2:0001248
EHDAA:1498
EHDAA:255
EMAPA:16073
EV:0100004
FBbt:00001061
FMA:87657
MAT:0000176
MIAA:0000176
ncithesaurus:Neuroectoderm
TAO:0001120
VHOG:0000150
XAO:0000042

ZFA:0001120
Synonyms: "epithelium tubi neuralis; neuroectoderma" RELATED LATIN [Wikipedia:Neuroectoderm]
"neuaral ectoderm" RELATED []
"neural ectoderm" EXACT []
"neuroectoderm" EXACT []
"presumptive central nervous system" RELATED []
Comments:Terminology notes: we prefer neurectoderm to neural ectoderm since placodal ectoderm is not classified here
Alt_id: UBERON:FMA_87657-MIAA_0000176-XAO_0000042-ZFA_0001120
Subset: uberon_slim
vertebrate_core

Ontology association
Each term has an is_a parent in the Uberon Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to UBERON ontologies.

link to ontology dataset
data


Parents

is_a:UBERON:0000923(germ layer),UBERON:0004121(ectoderm-derived structure)
develops_from:UBERON:0000924(ectoderm)



Children

is a:FF:10637-108I7 (neuroectodermal tumor cell line:FU-RPNT-1),FF:10663-109C6 (neuroectodermal tumor cell line:FU-RPNT-2),FF:10697-109G4 (peripheral neuroectodermal tumor cell line:KU-SN),FF:10774-110F9 (neuroectodermal tumor cell line:TASK1)
develops from:UBERON:0001775 (ciliary body),UBERON:0003050 (olfactory placode),UBERON:0003075 (neural plate),UBERON:0004128 (optic vesicle),UBERON:0007284 (presumptive neural plate)
part of:UBERON:0002342 (neural crest),UBERON:0003075 (neural plate),UBERON:0006238 (future brain)

Ontology Tree: Loaded from BioPortal


FF samples
It includes FANTOM5 samples that overlay the Uberon ontology


Human (Homo sapiens)

  • 10637-108I7 (neuroectodermal tumor cell line:FU-RPNT-1)
  • 10663-109C6 (neuroectodermal tumor cell line:FU-RPNT-2)
  • 10697-109G4 (peripheral neuroectodermal tumor cell line:KU-SN)
  • 10774-110F9 (neuroectodermal tumor cell line:TASK1)


Enrichment analysis: top 100 FFCP enriched with this ontology term TOP 100 FANTOM5 Cage Peaks enriched with UBERON:0002346 (neurectoderm), sorted by p-values
Analyst: Hideya Kawaji

link to source dataset
human : data
mouse : data


P-valueFFCPShort description
4.32e-103FFCP PHASE1:Hg19::chr5:11588907..11588967,-#_bd062af150aa963ed51e7e9d934ed8efp3@CTNND2
4.32e-103FFCP PHASE2:Hg19::chr5:11588907..11588967,-#_bd062af150aa963ed51e7e9d934ed8efp3@CTNND2
2.11e-102FFCP PHASE1:Hg19::chr11:31839488..31839515,-#_8dc4b39ace8db98571f91e9642041862p3@PAX6
2.11e-102FFCP PHASE2:Hg19::chr11:31839488..31839515,-#_8dc4b39ace8db98571f91e9642041862p3@PAX6
1.77e-98FFCP PHASE2:Hg19::chr17:54230819..54230848,+#_c1c1ede1ef4df0d8ec9eeac91abc8be4p1@ANKFN1
1.77e-98FFCP PHASE1:Hg19::chr17:54230819..54230848,+#_c1c1ede1ef4df0d8ec9eeac91abc8be4p1@ANKFN1
2.49e-97FFCP PHASE1:Hg19::chr4:165305086..165305179,-#_cd57bb4c92e029287be62bb4bed16ba2p2@MARCH1
2.49e-97FFCP PHASE2:Hg19::chr4:165305086..165305179,-#_cd57bb4c92e029287be62bb4bed16ba2p2@MARCH1
2.85e-95FFCP PHASE1:Hg19::chr2:74612644..74612670,+#_1d96d1a8ec231b01f41e5c3fa438eea8p1@ENST00000412957
2.85e-95FFCP PHASE2:Hg19::chr2:74612644..74612670,+#_1d96d1a8ec231b01f41e5c3fa438eea8p1@ENST00000412957
3.65e-95FFCP PHASE1:Hg19::chr5:87439352..87439386,-#_c472a433a31db705ca50e4e0aecce02ap@chr5:87439352..87439386, -
3.65e-95FFCP PHASE2:Hg19::chr5:87439352..87439386,-#_c472a433a31db705ca50e4e0aecce02ap@chr5:87439352..87439386, -
1.65e-94FFCP PHASE2:Hg19::chr5:87980761..87980821,-#_78b99d73b7566a84611a5b6a3d0a194ap4@LINC00461
1.65e-94FFCP PHASE1:Hg19::chr5:87980761..87980821,-#_78b99d73b7566a84611a5b6a3d0a194ap4@LINC00461
1.56e-93FFCP PHASE1:Hg19::chr5:11384884..11384916,-#_8e1d297cf484e5f41dd6410283478271p8@CTNND2
1.56e-93FFCP PHASE2:Hg19::chr5:11384884..11384916,-#_8e1d297cf484e5f41dd6410283478271p8@CTNND2
1.77e-93FFCP PHASE2:Hg19::chr12:106976678..106976708,+#_1e247056b5d86a89ca60fc29f2a74b66p2@RFX4
1.77e-93FFCP PHASE1:Hg19::chr12:106976678..106976708,+#_1e247056b5d86a89ca60fc29f2a74b66p2@RFX4
2.16e-93FFCP PHASE1:Hg19::chr2:50201220..50201261,-#_da56ce4e11f4dbd3bd4dc9ccbe56ab84p3@NRXN1
2.16e-93FFCP PHASE2:Hg19::chr2:50201220..50201261,-#_da56ce4e11f4dbd3bd4dc9ccbe56ab84p3@NRXN1
3.46e-93FFCP PHASE1:Hg19::chr9:19789059..19789070,-#_c5539c3439ea4d11fac2c6d4602ab5fdp2@SLC24A2
3.46e-93FFCP PHASE2:Hg19::chr9:19789059..19789070,-#_c5539c3439ea4d11fac2c6d4602ab5fdp2@SLC24A2
4.22e-93FFCP PHASE1:Hg19::chr18:32398296..32398318,+#_cc3c4012c91c5a58c14b88842203841fp7@DTNA
4.22e-93FFCP PHASE2:Hg19::chr18:32398296..32398318,+#_cc3c4012c91c5a58c14b88842203841fp7@DTNA
6.23e-93FFCP PHASE2:Hg19::chr8:18541544..18541592,-#_376611e6a68c61ba611de00387f92a9cp2@PSD3
6.23e-93FFCP PHASE1:Hg19::chr8:18541544..18541592,-#_376611e6a68c61ba611de00387f92a9cp2@PSD3
1.56e-92FFCP PHASE2:Hg19::chr11:62475005..62475041,-#_e7da1fb647ba04cbe195713c3cc7b9a5p6@BSCL2
1.56e-92FFCP PHASE1:Hg19::chr11:62475005..62475041,-#_e7da1fb647ba04cbe195713c3cc7b9a5p6@BSCL2
2.16e-92FFCP PHASE2:Hg19::chr5:146314142..146314146,-#_2c9d469415df6818e5ddd345a882197ep@chr5:146314142..146314146, -
2.16e-92FFCP PHASE1:Hg19::chr5:146314142..146314146,-#_2c9d469415df6818e5ddd345a882197e-, p@chr5:146314142..146314146
4.94e-92FFCP PHASE2:Hg19::chr12:20848486..20848542,+#_7e08cc427ec23c56f9dc3e1518602a3ep1@SLCO1C1
4.94e-92FFCP PHASE1:Hg19::chr12:20848486..20848542,+#_7e08cc427ec23c56f9dc3e1518602a3ep1@SLCO1C1
9.18e-92FFCP PHASE1:Hg19::chrX:139803820..139803865,+#_89c074be138cf86bbfc34aa4fd195316p@chrX:139803820..139803865, +
9.18e-92FFCP PHASE2:Hg19::chrX:139803820..139803865,+#_89c074be138cf86bbfc34aa4fd195316p@chrX:139803820..139803865, +
1.02e-91FFCP PHASE2:Hg19::chr17:36760961..36760976,-#_40a91a2b19ff1dd240aef9d4d74c8f28p2@SRCIN1
1.02e-91FFCP PHASE1:Hg19::chr17:36760961..36760976,-#_40a91a2b19ff1dd240aef9d4d74c8f28p2@SRCIN1
1.19e-91FFCP PHASE1:Hg19::chr4:46126009..46126045,-#_b62c2782e16c014a9403881933c2ce09p1@GABRG1
1.19e-91FFCP PHASE2:Hg19::chr4:46126009..46126045,-#_b62c2782e16c014a9403881933c2ce09p1@GABRG1
2.32e-91FFCP PHASE1:Hg19::chr19:30016395..30016433,+#_7d6b4417a17eb425a0d916ab2bdafffbp@chr19:30016395..30016433, +
2.32e-91FFCP PHASE2:Hg19::chr19:30016395..30016433,+#_7d6b4417a17eb425a0d916ab2bdafffb+, p@chr19:30016395..30016433
3.27e-91FFCP PHASE2:Hg19::chr5:11386115..11386130,-#_62a95ab462e4e382a1ccc674d92d8cdbp2@CTNND2
3.27e-91FFCP PHASE1:Hg19::chr5:11386115..11386130,-#_62a95ab462e4e382a1ccc674d92d8cdbp2@CTNND2
5.78e-91FFCP PHASE1:Hg19::chr15:46702499..46702523,+#_04914067a754282c3e6a0eae38dcf7fap@chr15:46702499..46702523, +
5.78e-91FFCP PHASE2:Hg19::chr15:46702499..46702523,+#_04914067a754282c3e6a0eae38dcf7fap@chr15:46702499..46702523, +
6.2e-91FFCP PHASE1:Hg19::chr12:106976656..106976672,+#_7d0d999631f1334f0b4bd977a7d1e50cp4@RFX4
6.2e-91FFCP PHASE2:Hg19::chr12:106976656..106976672,+#_7d0d999631f1334f0b4bd977a7d1e50cp4@RFX4
6.65e-91FFCP PHASE2:Hg19::chr1:84630574..84630602,+#_b75f839fcc859b72b9d629eec8c8c392p9@PRKACB
6.65e-91FFCP PHASE1:Hg19::chr1:84630574..84630602,+#_b75f839fcc859b72b9d629eec8c8c392p9@PRKACB
9.73e-91FFCP PHASE2:Hg19::chrX:13835398..13835429,-#_4f20beee53d81507f1e288c053ca23d7p6@GPM6B
9.73e-91FFCP PHASE1:Hg19::chrX:13835398..13835429,-#_4f20beee53d81507f1e288c053ca23d7p6@GPM6B
9.99e-91FFCP PHASE2:Hg19::chr1:84630610..84630621,+#_cc687b30f3da5ea98248b2de63b4d57cp17@PRKACB
9.99e-91FFCP PHASE1:Hg19::chr1:84630610..84630621,+#_cc687b30f3da5ea98248b2de63b4d57cp17@PRKACB
1.35e-90FFCP PHASE2:Hg19::chr6:136848260..136848296,-#_16ecab561d68d6dd49337d21c2a6c42fp4@MAP7
1.35e-90FFCP PHASE1:Hg19::chr6:136848260..136848296,-#_16ecab561d68d6dd49337d21c2a6c42fp4@MAP7
1.57e-90FFCP PHASE1:Hg19::chr16:4850844..4850888,-#_99f65588b38ad6115e340d84aa08c89ep@chr16:4850844..4850888, -
1.57e-90FFCP PHASE2:Hg19::chr16:4850844..4850888,-#_99f65588b38ad6115e340d84aa08c89ep@chr16:4850844..4850888, -
2.14e-90FFCP PHASE1:Hg19::chr10:62149542..62149590,-#_3f2246a6b1dbd14c4746d1ab1fca6e06p1@ANK3
2.14e-90FFCP PHASE2:Hg19::chr10:62149542..62149590,-#_3f2246a6b1dbd14c4746d1ab1fca6e06p1@ANK3
2.39e-90FFCP PHASE2:Hg19::chr9:87283501..87283520,+#_c8b347a5f7836a39f893dab48f809250p17@NTRK2
2.39e-90FFCP PHASE1:Hg19::chr9:87283501..87283520,+#_c8b347a5f7836a39f893dab48f809250p17@NTRK2
2.61e-90FFCP PHASE2:Hg19::chr1:2005182..2005194,+#_38acf2b18b60af807dac980dfe535c2dp8@PRKCZ
2.61e-90FFCP PHASE1:Hg19::chr1:2005182..2005194,+#_38acf2b18b60af807dac980dfe535c2dp8@PRKCZ
4.63e-90FFCP PHASE1:Hg19::chr6:80131670..80131724,+#_8544af35a0fefb192a15b943778ba76fp@chr6:80131670..80131724, +
4.63e-90FFCP PHASE2:Hg19::chr6:80131670..80131724,+#_8544af35a0fefb192a15b943778ba76f+, p@chr6:80131670..80131724
4.84e-90FFCP PHASE1:Hg19::chr12:106976774..106976788,+#_df3ea3fc2216b355676ab100f9ae2f60p1@RFX4
4.84e-90FFCP PHASE2:Hg19::chr12:106976774..106976788,+#_df3ea3fc2216b355676ab100f9ae2f60p1@RFX4
5.68e-90FFCP PHASE2:Hg19::chr13:25746318..25746350,-#_976b4ddb15056d073786de4fb917d83bp3@FAM123A
5.68e-90FFCP PHASE1:Hg19::chr13:25746318..25746350,-#_976b4ddb15056d073786de4fb917d83bp3@FAM123A
7.47e-90FFCP PHASE2:Hg19::chr5:160279207..160279247,-#_fce8ade68f5ab3a23b04ec56ac3afecep1@ATP10B
7.47e-90FFCP PHASE1:Hg19::chr5:160279207..160279247,-#_fce8ade68f5ab3a23b04ec56ac3afecep1@ATP10B
8.65e-90FFCP PHASE1:Hg19::chr4:46126063..46126087,-#_efc8830fb9cc84121323a27221deec76p2@GABRG1
8.65e-90FFCP PHASE2:Hg19::chr4:46126063..46126087,-#_efc8830fb9cc84121323a27221deec76p2@GABRG1
8.97e-90FFCP PHASE2:Hg19::chr16:76311254..76311274,+#_21c7492d5be9069555b921c34bd3f89dp2@CNTNAP4
8.97e-90FFCP PHASE1:Hg19::chr16:76311254..76311274,+#_21c7492d5be9069555b921c34bd3f89dp2@CNTNAP4
2.17e-89FFCP PHASE2:Hg19::chr7:47420733..47420758,-#_3e4fdfaeed64019643743390380a6b27-, p@chr7:47420733..47420758
2.17e-89FFCP PHASE1:Hg19::chr7:47420733..47420758,-#_3e4fdfaeed64019643743390380a6b27-, p@chr7:47420733..47420758
2.55e-89FFCP PHASE1:Hg19::chrX:13835312..13835321,-#_8d139e3539f377ef2ac6ba76c22b5e05p9@GPM6B
2.55e-89FFCP PHASE2:Hg19::chrX:13835312..13835321,-#_8d139e3539f377ef2ac6ba76c22b5e05p9@GPM6B
2.57e-89FFCP PHASE1:Hg19::chr5:112074041..112074101,+#_287882d2e37a57738bb3ad1741d8d485p4@APC
2.57e-89FFCP PHASE2:Hg19::chr5:112074041..112074101,+#_287882d2e37a57738bb3ad1741d8d485p4@APC
2.87e-89FFCP PHASE1:Hg19::chr2:74612614..74612643,+#_1b988fb3548f32e14af0000397805d64p1@ENST00000418990, p1@ENST00000426715, p1@ENST00000427343
2.87e-89FFCP PHASE2:Hg19::chr2:74612614..74612643,+#_1b988fb3548f32e14af0000397805d64p1@ENST00000418990, p1@ENST00000426715, p1@ENST00000427343
7.17e-89FFCP PHASE1:Hg19::chr18:32398400..32398416,+#_e2291f5f0c22d1600291fa7b663e02eap10@DTNA
7.17e-89FFCP PHASE2:Hg19::chr18:32398400..32398416,+#_e2291f5f0c22d1600291fa7b663e02eap10@DTNA
8.04e-89FFCP PHASE2:Hg19::chr17:68101117..68101162,+#_75e12a2cb5a2e2487cd094f9940f29c6p2@KCNJ16
8.04e-89FFCP PHASE1:Hg19::chr17:68101117..68101162,+#_75e12a2cb5a2e2487cd094f9940f29c6p2@KCNJ16
8.72e-89FFCP PHASE1:Hg19::chr18:32398372..32398394,+#_e4906d31ef8775238cc003dd027a4a80p5@DTNA
8.72e-89FFCP PHASE2:Hg19::chr18:32398372..32398394,+#_e4906d31ef8775238cc003dd027a4a80p5@DTNA
9.14e-89FFCP PHASE1:Hg19::chr17:42989121..42989166,-#_04ed10eee94b5349558cd56e7b554f45p7@GFAP
9.14e-89FFCP PHASE2:Hg19::chr17:42989121..42989166,-#_04ed10eee94b5349558cd56e7b554f45p7@GFAP
2.05e-88FFCP PHASE2:Hg19::chr6:56716896..56716928,-#_0ad1530a3a573e756cbf3b231ea01ec1p8@DST
2.05e-88FFCP PHASE1:Hg19::chr6:56716896..56716928,-#_0ad1530a3a573e756cbf3b231ea01ec1p8@DST
2.12e-88FFCP PHASE1:Hg19::chr5:11384929..11384947,-#_682c44bd4c3ef61699d2e042cca0133bp15@CTNND2
2.12e-88FFCP PHASE2:Hg19::chr5:11384929..11384947,-#_682c44bd4c3ef61699d2e042cca0133bp15@CTNND2
2.37e-88FFCP PHASE2:Hg19::chr10:25940658..25940700,+#_aa2b9aa533272dcb43be94f704f2838dp1@ENST00000450270
2.37e-88FFCP PHASE1:Hg19::chr10:25940658..25940700,+#_aa2b9aa533272dcb43be94f704f2838dp1@ENST00000450270
2.7e-88FFCP PHASE1:Hg19::chr17:7558857..7558903,+#_ba693a8adbf4405b75e2863ea0d14156p@chr17:7558857..7558903, +
2.7e-88FFCP PHASE2:Hg19::chr17:7558857..7558903,+#_ba693a8adbf4405b75e2863ea0d14156p@chr17:7558857..7558903, +
2.76e-88FFCP PHASE2:Hg19::chr15:30261066..30261096,-#_5f45967e8cbb0b0853110215131eae33p12@TJP1
2.76e-88FFCP PHASE1:Hg19::chr15:30261066..30261096,-#_5f45967e8cbb0b0853110215131eae33p12@TJP1